Postremission therapy in adults with acute myeloid leukemia

被引：11

作者：

Stone, RM ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

SEMINARS IN HEMATOLOGY | 2001年 / 38卷 / 03期

关键词：

D O I：

10.1016/S0037-1963(01)90152-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：17 / 23

页数：7

共 43 条

[1] Interleukin 2 in the treatment of acute leukemia [J].

Blaise, D ;

Maraninchi, D .

LEUKEMIA RESEARCH, 1998, 22 (12) :1165-1170

[2]

Bloomfield CD, 1998, CANCER RES, V58, P4173

[3] Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial [J].

Burnett, AK ;

Goldstone, AH ;

Stevens, RMF ;

Hann, IM ;

Rees, JKH ;

Gray, RG ;

Wheatley, K .

LANCET, 1998, 351 (9104) :700-708

[4] Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered [J].

Byrd, JC ;

Dodge, RK ;

Carroll, A ;

Baer, MR ;

Edwards, C ;

Stamberg, J ;

Qumsiyeh, M ;

Moore, JO ;

Mayer, RJ ;

Davey, F ;

Schiffer, CA ;

Bloomfield, CD .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) :3767-3775

[5] Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission [J].

Cassileth, PA ;

Harrington, DP ;

Appelbaum, FR ;

Lazarus, HM ;

Rowe, JM ;

Paietta, E ;

Willman, C ;

Hurd, DD ;

Bennett, JM ;

Blume, KG ;

Head, DR ;

Wiernik, PH .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (23) :1649-1656

[6]

CASSILETH PA, 1992, BLOOD, V79, P1924

[7]

CASSILETH PA, 1984, BLOOD, V63, P834

[8]

Champlin R, 1996, ACTA HAEMATOL-BASEL, V95, P157

[9] CD34+ acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells [J].

Cignetti, A ;

Bryant, E ;

Allione, B ;

Vitale, A ;

Foa, R ;

Cheever, MA .

BLOOD, 1999, 94 (06) :2048-2055

[10]

CLIFT R, 1992, LEUKEMIA, V6, P104

← 1 2 3 4 5 →